$CRVS 4 SEC Filings

Filed On	Filing
15 Jun 2026	Form 4: Moore David Scott, Director Bought 21,700 shares ($250K) · Granted 15,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Clark Ian T, Director Granted 15,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Grais Linda, Director Granted 15,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Thompson Peter A., Director Granted 15,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: van den Broek Richard, Director Granted 15,000 Stock Option (Right to Buy)
20 May 2026	Form 4: Miller Richard A Md, Director Bought 6,932 shares ($83.5K)
27 Apr 2026	Form 4: Chan Andrew C., Director Granted 30,000 Stock Option (Right to Buy)
30 Jan 2026	Form 4: Thompson Peter A., Director Received 210,000 shares by exercise or conversion ($1.12M)
08 Dec 2025	Form 4: Jones William Benton, See Remarks Granted 400,000 Stock Option (Right to Buy)
08 Dec 2025	Form 4: Miller Richard A Md, Director Granted 1,000,000 Stock Option (Right to Buy)
08 Dec 2025	Form 4: Arcara Jeffrey, Chief Business Officer Granted 100,000 Stock Option (Right to Buy)
08 Dec 2025	Form 4: Lea Leiv, Chief Financial Officer Granted 400,000 Stock Option (Right to Buy)
06 Oct 2025	Form 4: Moore David Scott, Director Granted 30,000 Stock Option (Right to Buy)
01 Jul 2025	Form 4: Orbimed Advisors Llc, Director and 1 other Received 1,397,684 shares by exercise ($4.89M) · Sold 1,176,332 shares ($4.89M)
01 Jul 2025	Form 4: Thompson Peter A., Director Received 1,397,684 shares by exercise ($4.89M) · Sold 1,176,332 shares ($4.89M)
16 Jun 2025	Form 4: Grais Linda, Director Granted 15,000 Stock Option (Right to Buy)
16 Jun 2025	Form 4: Clark Ian T, Director Granted 15,000 Stock Option (Right to Buy)
16 Jun 2025	Form 4: Morrison Scott W, Director Granted 15,000 Stock Option (Right to Buy)
16 Jun 2025	Form 4: Thompson Peter A., Director Granted 15,000 Stock Option (Right to Buy)
06 Jun 2025	Form 4: Jones William Benton, See Remarks Received 19,357 shares by exercise or conversion ($67.7K)

Comments